Glucagon-Like Peptide-1
A Novel Pancreatropic Coxsackievirus Vector Expressing Glucagon-Like Peptide 1 Reduces Hyperglycemia in Streptozotocin-Treated Mice
10
The peptide agonist-binding site of the glucagon-like peptide-1 (GLP-1) receptor based on site-directed mutagenesis and knowledge-based modelling
13
Differential effects of glucagon-like peptide-1 receptor agonists on heart rate
10
Glucagon like peptide 1 promotes satiety and suppresses energy intake in humans
7
Glucagon-like peptide-1 receptor agonists: a systematic review of comparative effectiveness research
17
Glucagon like peptide 1 receptors in the brain: controlling food intake and body weight
5
Long-term management of type 2 diabetes with glucagon-like peptide-1 receptor agonists
9
Glucagon like peptide 1 can reverse the age related decline in glucose tolerance in rats
8
Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies
5
GLP-1(28-36)amide, the Glucagon-like peptide-1 metabolite: friend, foe, or pharmacological folly?
12
A mechanism for agonist activation of the glucagon-like peptide-1 (GLP-1) receptor through modelling & molecular dynamics
37
Exendin(9 39)amide is an antagonist of glucagon like peptide 1(7 36)amide in humans
11
Hepatic and glucagon like peptide 1–mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors
12
Age dependent human β cell proliferation induced by glucagon like peptide 1 and calcineurin signaling
11
64Cu Labeled Sarcophagine Exendin-4 for MicroPET Imaging of Glucagon like Peptide-1 Receptor Expression
8
Elevated circulating fasting glucagon-like peptide-1 in surgical patients with aortic valve disease and diabetes
8
Crosstalk between FXR and TGR5 controls glucagon-like peptide 1 secretion to maintain glycemic homeostasis
7
Glucagon-like peptide-1 (GLP-1) mediates the protective effects of dipeptidyl peptidase IV inhibition on pulmonary hypertension
11
Glucagon-like peptide 1 receptor stimulation reverses key deficits in distinct rodent models of Parkinson's disease
9
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
24